GLP-1 Resources

Stopping treatment is not simply the reverse of starting it. GLP-1-based medications change appetite, satiety, food preoccupation, and energy intake while you take them. When treatment is withdrawn, those effects can diminish and appetite may rise again. Weight regain after discontinuation is common in clinical trials, which reflects the chronic biology of obesity rather than a failure of willpower.

Before stopping, clarify why

• Side effects may be addressed by a slower titration, dose reduction, nutrition changes, or a different medication.
• Cost or coverage problems may have different solutions than stopping for pregnancy, a procedure, or a completed treatment goal.
• If pregnancy is planned, use the medication-specific washout plan from your clinician; semaglutide should be stopped at least 2 months before planned conception.

Build the maintenance plan first

Expect hunger and food cues to change. Keep meal structure, adequate protein, resistance training, regular aerobic activity, sleep, and self-monitoring in place. Resistance exercise is especially important because preserving muscle helps support function and energy expenditure.

Exercise math matters

As body weight decreases, the calories required to move the body also decrease. Exercise is valuable for cardiovascular health, mood, strength, function, and weight maintenance, but it usually cannot fully offset a major return of appetite by itself. Think of activity as one part of a maintenance system rather than a calorie-for-calorie replacement for medication.

Monitor early

Agree on what change should trigger reassessment - for example, a sustained upward weight trend, increasing waist circumference, loss of control over hunger, or return of obesity-related conditions. Earlier adjustment is generally easier than waiting for substantial regain.

A plateau does not automatically mean the medication stopped working. Weight loss itself lowers energy requirements, and the rate of loss usually slows over time. Short plateaus can also reflect fluid shifts, constipation, menstrual changes, sodium intake, travel, or changes in activity.

First, define the plateau

Use trends rather than a few days on the scale. Review several weeks of weights under reasonably similar conditions and consider waist circumference, clothing fit, strength, and metabolic health as well.

Reassess the whole treatment plan

• Confirm the medication is being taken consistently and the dose is appropriate and tolerated.
• Look for calorie creep from drinks, alcohol, snacks, restaurant meals, or larger portions as appetite adapts.
• Make sure intake has not become too low to support protein, micronutrients, and resistance training.
• Review sleep, stress, medications that promote weight gain, constipation, and changes in daily movement.
• Progress resistance training rather than relying only on additional cardio.

Do not automatically chase the maximum dose

Some patients benefit from further titration when clinically appropriate, while others do better by staying at a lower effective dose. Wegovy injection now has an adult obesity option up to 7.2 mg weekly for patients who have tolerated 2.4 mg for at least 4 weeks and need additional weight reduction. Dose decisions should be individualized rather than driven by the scale alone.

When the plateau may actually be maintenance

If health markers have improved and the current weight is sustainable, the next phase may be maintenance rather than continued pursuit of a lower number.

Reaching a goal weight is a transition from active loss to long-term disease management. There is no requirement to stop medication simply because a target number has been reached. Obesity is commonly chronic and relapsing, and continued pharmacotherapy may be appropriate.

Define the new goal

Shift attention toward weight stability, waist circumference, strength, fitness, blood pressure, glucose and lipids when relevant, sleep, mobility, and quality of life.

Medication strategy

Your maintenance plan may involve continuing the effective dose, using a different maintenance dose, switching formulation, or eventually tapering/discontinuing with a monitoring plan. Do not improvise dose spacing or pen clicks unless specifically instructed for your prescribed product.

Protect what helped you succeed

• Continue structured resistance training and regular aerobic activity.
• Maintain adequate, individualized protein and hydration.
• Keep the meal patterns that work with your hunger and schedule.
• Continue periodic follow-up even when things are going well.

Expect a range, not one perfect number

Normal weight varies from day to day. A maintenance range is often more useful than trying to defend one exact scale number. Decide in advance what sustained change would prompt a check-in rather than reacting to every fluctuation.